SARTORIUS – Biostat STR®Generation 3
Biostat STR® single-use bioreactors and the Biobrain® automation platform offer multiple configurations and convenient software upgrades to quickly adapt facilities as requirements change. The Generation 3 system is now available with integrated Repligen XCell ATF® Technology for intensified processes and access to our best-in-class BioPAT® toolbox. Biostat STR® bioreactors and Flexsafe STR® bags range from 50 L to 2,000 L and can enhance speed, quality, and flexibility in process development and commercial manufacturing operations.
Available in :
The Biostat STR® Generation 3 with Biobrain® Automation Platform
Engineered for Ultimate Upstream Performance
Key Features
Biostat STR® Generation 3
The Biostat STR® Generation 3 single-use bioreactors are powered by the GMP compliant automation platform Biobrain® and come with a comprehensive suite of analytical tools. Ready for process intensification through integrated Repligen XCell ATF® Technology, the Biostat STR® can help enhance productivity, reduce footprint and lower COGs of your facility. The system can be used fully standalone or easily integrates into existing automation infrastructures and consistently delivers outstanding performance, quality, and productivity supporting manufacturers as they bring safe, effective, and affordable life-changing biopharmaceuticals to market.
- Stay flexible and optimize space
- Reduce operating expenses · Minimize risk
- Achieve superior process control
- Improve productivity and ease of use
- Increase facility throughput
Sartorius – Biostat STR® Generation 3
The new Biostat STR Generation 3 single-use bioreactor and Biobrain automation platform supports intensified bioprocessing and integration to DCS systems including native DeltaV™. The system is available with multiple options and configurations so that you can adapt to changing demand in pilot or GMP production environments.
Key Industries
- Biopharmaceutical and Biotechnology
The Sartorius Group is a leading international partner of the biopharmaceutical industry and the research sector. We are helping biotech…
